Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M.G. Kris
Comparison of CT Volumetric Measurement With RECIST Response in Patients With Lung Cancer
European Journal of Radiology
Medicine
Nuclear Medicine
Radiology
Imaging
Related publications
Erratum To: Therapy Response in Malignant Pleural Mesothelioma-Role of MRI Using RECIST, Modified RECIST and Volumetric Approaches in Comparison With CT
European Radiology
Medicine
Nuclear Medicine
Radiology
Imaging
New Response Evaluation Criteria in Solid Tumors (RECIST) Guidelines for Advanced Non–Small Cell Lung Cancer: Comparison With Original RECIST and Impact on Assessment of Tumor Response to Targeted Therapy
American Journal of Roentgenology
Medicine
Nuclear Medicine
Radiology
Imaging
Lung Cancer Screening With CT
Clinics in Chest Medicine
Pulmonary
Respiratory Medicine
Response Criteria in Solid Tumors (PERCIST/RECIST) and SUVmax in Early-Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
P2.01-55 Dual-Energy CT Scan to Evaluate Sarcopenia in Lung Cancer in Comparison With Conventional CT Scan
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
68Ga-Nota-Prgd2 PET/CT for Integrin Imaging in Patients With Lung Cancer
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Clinical and Prognostic Significance of Lupus Anticoagulant Measurement in Patients With Lung Cancer
Technology in Cancer Research and Treatment
Medicine
Cancer Research
Oncology
Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients With Metastatic Colorectal Cancer Treated With Irinotecan and Cetuximab
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Feasibility of Continuing Crizotinib Therapy After RECIST-PD in Advanced Non-Small Cell Lung Cancer Patients With ALK/ROS-1 Mutations
Journal of Cancer
Oncology